Science-driven drug development
Biotech investors understand long development timelines, high failure rates, and the potential for transformative returns. Your pitch must demonstrate scientific rigor, a clear regulatory pathway, and capital-efficient development strategy.
Current phase of clinical development (preclinical, Phase 1/2/3).
Benchmark: Seed: preclinical, Series A: entering Phase 1, Series B: Phase 2 data.
Efficacy and safety data from trials.
Benchmark: Statistical significance vs. placebo or standard of care.
Patent portfolio, composition of matter, and exclusivity.
Benchmark: 10+ years of patent protection remaining.
Months of operations funded to next value inflection.
Benchmark: 18-24 months minimum to next milestone.
Total addressable patient population and pricing.
Benchmark: Peak sales potential based on similar approved drugs.
Explain how your drug works
Map the path to approval
Position against other treatments
Use Pitchkit to create a professional biotech pitch deck with AI-powered feedback.